Viridian Therapeutics, Inc./DE Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Viridian Therapeutics, Inc./DE stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $693.00K.
- Viridian Therapeutics, Inc./DE stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $5.00M.
- Viridian Therapeutics, Inc./DE stock issued during period, value, issued for services for fiscal 2023 was $5.69M.
- Viridian Therapeutics, Inc./DE stock issued during period, value, issued for services for fiscal 2021 was $7.50M, a 25.00% increase from fiscal 2020.
- Viridian Therapeutics, Inc./DE stock issued during period, value, issued for services for fiscal 2020 was $6.00M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $5.69M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $693.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $5.00M 10-Q · filed 2024-11-12 | |
| 2021-12-31 | $7.50M 10-K · filed 2024-02-27 | |
| 2020-12-31 | $6.00M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |